Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities.
arthritis
bone marrow transplantation
comorbidities
epigenetic rewiring
hematopoietic stem and progenitor cells
inflammation
myelopoiesis
periodontitis
trained immunity
Journal
Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066
Informations de publication
Date de publication:
12 05 2022
12 05 2022
Historique:
received:
11
08
2021
revised:
22
02
2022
accepted:
30
03
2022
pubmed:
29
4
2022
medline:
18
5
2022
entrez:
28
4
2022
Statut:
ppublish
Résumé
Bone marrow (BM)-mediated trained innate immunity (TII) is a state of heightened immune responsiveness of hematopoietic stem and progenitor cells (HSPC) and their myeloid progeny. We show here that maladaptive BM-mediated TII underlies inflammatory comorbidities, as exemplified by the periodontitis-arthritis axis. Experimental-periodontitis-related systemic inflammation in mice induced epigenetic rewiring of HSPC and led to sustained enhancement of production of myeloid cells with increased inflammatory preparedness. The periodontitis-induced trained phenotype was transmissible by BM transplantation to naive recipients, which exhibited increased inflammatory responsiveness and disease severity when subjected to inflammatory arthritis. IL-1 signaling in HSPC was essential for their maladaptive training by periodontitis. Therefore, maladaptive innate immune training of myelopoiesis underlies inflammatory comorbidities and may be pharmacologically targeted to treat them via a holistic approach.
Identifiants
pubmed: 35483374
pii: S0092-8674(22)00393-2
doi: 10.1016/j.cell.2022.03.043
pmc: PMC9106933
mid: NIHMS1794730
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1709-1727.e18Subventions
Organisme : NIDCR NIH HHS
ID : R01 DE028561
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE029436
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE031206
Pays : United States
Organisme : British Heart Foundation
ID : RE/18/5/34216
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests M.G.N. is the scientific founder and member of the Scientific Advisory Board of Trained Therapeutics and Discovery (TTxD). M.G.N. has two patents: US18/61935 (Targeted nanoimmunotherapy to increase trained immunity) and US18/61939 (Targeted nanoimmunotherapy for inhibition of trained immunity). The other authors declare no competing interests.
Références
J Dent Res. 2014 Nov;93(11):1045-53
pubmed: 25261053
Elife. 2014 Jul 15;3:
pubmed: 25027438
Nat Rev Rheumatol. 2017 Oct;13(10):606-620
pubmed: 28835673
J Clin Invest. 2020 Dec 1;130(12):6261-6277
pubmed: 32817592
Cell Stem Cell. 2015 Jul 2;17(1):35-46
pubmed: 26095048
JCI Insight. 2019 Jul 11;4(13):
pubmed: 31292292
Curr Oral Health Rep. 2017;4(1):1-7
pubmed: 28303212
Lancet. 2019 Jul 20;394(10194):249-260
pubmed: 31327369
J Immunol. 2001 Mar 1;166(5):3484-90
pubmed: 11207307
Cell Rep. 2020 May 19;31(7):107634
pubmed: 32433977
Mol Cell. 2018 Sep 6;71(5):858-871.e8
pubmed: 30078726
J Periodontol. 2021 Mar;92(3):348-358
pubmed: 33512014
Nat Immunol. 2021 Nov;22(11):1382-1390
pubmed: 34663978
J Infect Dis. 2020 Nov 9;222(11):1869-1881
pubmed: 31889191
Arthritis Res Ther. 2019 Jan 18;21(1):27
pubmed: 30658685
J Periodontol. 2020 Sep;91(9):1186-1193
pubmed: 31984496
J Am Coll Cardiol. 2011 Feb 22;57(8):971-6
pubmed: 21329844
Nat Protoc. 2006;1(5):2512-6
pubmed: 17406499
Nat Genet. 2021 Mar;53(3):403-411
pubmed: 33633365
J Clin Invest. 2017 Oct 2;127(10):3624-3639
pubmed: 28846069
PLoS Pathog. 2013 Sep;9(9):e1003627
pubmed: 24068934
Blood. 2016 Nov 10;128(19):2285-2296
pubmed: 27357698
J Dent Res. 2015 Oct;94(10):1355-61
pubmed: 26318590
Cell Host Microbe. 2020 Aug 12;28(2):322-334.e5
pubmed: 32544459
Trends Immunol. 2019 Jan;40(1):1-11
pubmed: 30503793
Science. 2021 Aug 27;373(6558):
pubmed: 34446580
Cell. 2020 Jul 23;182(2):447-462.e14
pubmed: 32758418
Innate Immun. 2015 Oct;21(7):714-25
pubmed: 26055820
J Clin Periodontol. 2011 Jun;38(6):532-41
pubmed: 21434962
Genome Biol. 2014;15(12):550
pubmed: 25516281
Science. 2015 Nov 6;350(6261):aab2006
pubmed: 26449473
Cell Rep. 2020 Nov 17;33(7):108387
pubmed: 33207187
Nat Cell Biol. 2016 Jun;18(6):607-18
pubmed: 27111842
Nat Immunol. 2019 Jan;20(1):40-49
pubmed: 30455459
J Immunol Methods. 2013 Aug 30;394(1-2):49-54
pubmed: 23672778
J Rheumatol. 2008 Jan;35(1):70-6
pubmed: 18050377
EClinicalMedicine. 2021 Aug 12;39:101049
pubmed: 34430834
Blood. 2013 May 30;121(22):4463-72
pubmed: 23564910
Sci Transl Med. 2015 Sep 30;7(307):307ra155
pubmed: 26424570
Curr Opin Rheumatol. 2014 Jul;26(4):424-9
pubmed: 24807405
Lancet Diabetes Endocrinol. 2018 Dec;6(12):954-965
pubmed: 30472992
Science. 2008 Jan 11;319(5860):202-6
pubmed: 18187655
Nat Immunol. 2021 Dec;22(12):1490-1502
pubmed: 34616036
Cell. 2018 May 31;173(6):1535-1548.e16
pubmed: 29706549
Cell Stem Cell. 2020 May 7;26(5):793
pubmed: 32386557
Sci Transl Med. 2016 Dec 14;8(369):369ra176
pubmed: 27974664
Am J Physiol Gastrointest Liver Physiol. 2018 Nov 1;315(5):G824-G837
pubmed: 30118351
J Periodontol. 2005 Feb;76(2):229-33
pubmed: 15974846
Periodontol 2000. 2020 Jun;83(1):7-13
pubmed: 32385880
Nat Immunol. 2019 Jul;20(7):802-811
pubmed: 31213716
Nat Rev Dis Primers. 2018 Feb 08;4:18001
pubmed: 29417936
Blood. 2005 Aug 1;106(3):1076-83
pubmed: 15840691
Cell. 2020 Oct 29;183(3):771-785.e12
pubmed: 33125892
Nat Rev Immunol. 2015 Jan;15(1):30-44
pubmed: 25534621
Nat Commun. 2018 Feb 16;9(1):701
pubmed: 29453398
Nat Rev Immunol. 2020 Jun;20(6):375-388
pubmed: 32132681
Arthritis Res Ther. 2016 May 21;18(1):115
pubmed: 27209093
Curr Opin Immunol. 2020 Aug;65:7-13
pubmed: 32220702
J Clin Invest. 2021 Oct 1;131(19):
pubmed: 34403362
Nature. 2009 Oct 8;461(7265):762-7
pubmed: 19767730
Periodontol 2000. 2020 Jun;83(1):90-106
pubmed: 32385879
Immunity. 2021 Jan 12;54(1):32-43
pubmed: 33220235
J Biol Chem. 2020 May 22;295(21):7261-7273
pubmed: 32280065
Nat Immunol. 2004 Aug;5(8):853-61
pubmed: 15258579
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Cell. 2018 Jan 11;172(1-2):176-190.e19
pubmed: 29328912
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2271-2273
pubmed: 31326471
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Sci Rep. 2017 Jul 31;7(1):6955
pubmed: 28761156
Front Immunol. 2016 Mar 02;7:80
pubmed: 26973655
EMBO J. 2013 Mar 6;32(5):645-55
pubmed: 23353889
Mol Cell Biol. 2012 Jul;32(14):2917-33
pubmed: 22615488
Cell. 2018 Jan 11;172(1-2):147-161.e12
pubmed: 29328910
Nature. 2019 Feb;566(7745):496-502
pubmed: 30787437
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Sci Transl Med. 2018 Oct 17;10(463):
pubmed: 30333238
Blood. 2005 Apr 1;105(7):2724-32
pubmed: 15598809
Nat Genet. 2018 Jul;50(7):1002-1010
pubmed: 29808031
Arthritis Rheumatol. 2014 May;66(5):1090-100
pubmed: 24782175
Nat Rev Immunol. 2021 Jul;21(7):426-440
pubmed: 33510490
Cell Rep. 2018 Dec 11;25(11):2992-3005.e5
pubmed: 30540934
Clin Epigenetics. 2018 Jun 28;10:89
pubmed: 29988283
Mol Aspects Med. 2021 Feb;77:100923
pubmed: 33160640
J Clin Periodontol. 2013 Apr;40 Suppl 14:S85-105
pubmed: 23627337
Iran J Immunol. 2008 Jun;5(2):100-6
pubmed: 18523355
Immunity. 2011 May 27;34(5):715-28
pubmed: 21565532